A clinical research consortium sponsored by NIAID and JDRF
about us
news
research
Clinical Trials
Core Facilities
Lab Protocols
Publications
proposals
careers
contact
Clinical Trials
Core Facilities
Lab Protocols
Publications
Home
Clinical Trials
Search
View A Specific Trial Category
<Any>
Allergy & Asthma
Asthma
Autoimmune Diseases
Islet Transplantation
Kidney Transplantation
Liver Transplantation
Lupus
Multiple Sclerosis
Peanut Allergy
Psoriatic Arthritis
Ragweed Allergy
Transplantation
Type 1 Diabetes
Vasculitis
Active
A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)
Principal Investigator:
Samia Khoury , Harvard Medical School, Boston, MA
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
A Phase I Trial of IL-2 and Sirolimus in Recent-onset Type 1 Diabetes Mellitus
Principal Investigator:
Carla Greenbaum, Virginia Mason Research Center
[
Details
] [
Clinicaltrials.gov
]
A Phase II study of multiple doses of hOKT3γ-1(Ala-Ala) for new onset type 1 diabetes (AbATE)
Principal Investigator:
Kevan Herold, Yale University, New Haven, CT
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
A Randomized, Double-blind, Single-center, Placebo-controlled Study of Sublingual Immunotherapy and Subcutaneous Immunotherapy in Adults with Seasonal Allergic Rhinitis (The GRASS Study)
Principal Investigator:
Stephen Durham, MD, Imperial College London
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
Abatacept and Cyclophosphamide Combination: Efficacy and Safety Study (ACCESS) for Lupus Nephritis
Principal Investigator:
David Wofsy, University of California San Francisco, CA Betty Diamond, Feinstein Institute, Manhasset, NY
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
An Observational Study to Assess the Prevalence of a Tolerance Signature in Renal Transplant Recipients (ARTIST)
Principal Investigator:
Kenneth Newell, Emory University, Atlanta, GA Laurence Turka, Harvard Medical School, Boston, MA Anil Chandraker, Harvard Medical School, Boston, MA
[
Details
]
Cytokine production in blood leukocytes of prediabetic children and effect of intranasal insulin
Principal Investigator:
Jorma Ilonen, University of Turku, Finland
[
Details
]
Effects of Intravenous Alpha-1 Antitrypsin on Preserving Beta-cell Function in New-onset Type 1 Diabetes Mellitus
Principal Investigator:
Gordon Weir , Joslin Diabetes Center, Boston, MA
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
Gradual Withdrawal of Immunosuppression in Patients Receiving a Liver Transplant (AWISH)
Principal Investigator:
Abraham Shaked, University of Pennsylvania, Philidelphia, PA
[
Details
] [
Clinicaltrials.gov
]
High dose immunosuppression and autologous transplantation for multiple sclerosis (HALT MS)
Principal Investigator:
Richard A. Nash, Fred Hutchinson Cancer Research Center, Seattle, WA
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
Immunosuppression Withdrawal for Pediatric Living-Donor Liver Transplant Recipients (WISP-R)
Principal Investigator:
Sandy Feng, University of California, San Francisco
[
Details
] [
Clinicaltrials.gov
]
Inducing Remission in Type 1 Diabetes with Alefacept (T1DAL)
Principal Investigator:
Mark Rigby MD PhD , Indiana University/Riley Hospital for Children, Indianapolis, IN
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
ITN Registry of Tolerant Kidney Transplant Recipients
Principal Investigator:
Kenneth Newell, Emory University
[
Details
] [
Study Website
]
Pilot Study to Determine the Immunogenicity of Immucothel® and Oral Tolerance Induction with Biosyn Native KLH in Healthy Subjects
Principal Investigator:
Lloyd Mayer, MD, Mount Sinai Medical Center, New York, NY
[
Details
] [
Clinicaltrials.gov
]
Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study
Principal Investigator:
Patrick Holt, University of Western Australia, Perth, AUS Peter Sly, Telethon Institute for Child Health Research, Perth, AUS
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
Promoting Tolerance to Peanut in High-Risk Children (LEAP)
Principal Investigator:
Gideon Lack, Evelina Children's Hospital, London, UK
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
Renal Allograft Tolerance through Mixed Chimerism
Principal Investigator:
David H. Sachs, MD, Harvard Medical School
[
Details
] [
Clinicaltrials.gov
]
Safety and Efficacy of Campath-1H and Tacrolimus Followed By Immunosuppression Withdrawal in Liver Transplantation
Principal Investigator:
J. Richard Thistlethwaite, University of Chicago, IL
[
Details
] [
Clinicaltrials.gov
]
Study of Thymoglobulin to Arrest Type 1 Diabetes (START)
Principal Investigator:
Stephen Gitelman, University of California, San Francisco
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
Completed
A Screening Study for Identification of Tolerance Markers in Liver Transplant Recipients Who Received Campath-1H Immunosuppression
Principal Investigator:
Andreas Tzakis, MD, Jackson Memorial Hospital Panagiotis Tryphonopoulos, MD, University of Miami
[
Details
]
Allergen ISS conjugates in allergic rhinitis
Principal Investigator:
Peter Creticos, Johns Hopkins University, Baltimore, MA
[
Details
]
Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis (STAYCIS)
Principal Investigator:
Scott Zamvil, University of California, San Francisco
[
Details
] [
Clinicaltrials.gov
]
Autoantigen vaccination in newly diagnosed type 1 diabetes mellitus
Principal Investigator:
Tihamer Orban, Joslin Diabetes Center, Boston, MA
[
Details
] [
Clinicaltrials.gov
]
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
Principal Investigator:
Flavio Vincenti, University of California, San Francisco, CA Christian Larsen, MD, Emory University, Atlanta, GA
[
Details
] [
Clinicaltrials.gov
]
Campath-1H/Tacrolimus/Sirolimus Withdrawal in Renal Transplantation
Principal Investigator:
Stuart Knechtle, University of Wisconsin, Madison, WI
[
Details
] [
Clinicaltrials.gov
]
Efficacy and Safety Evaluation of Allergen Immunotherapy Co-Administered with Omalizumab, an anti-IgE Monoclonal Antibody
Principal Investigator:
Thomas B. Casale, Creighton University School of Medicine
[
Details
] [
Clinicaltrials.gov
]
Mixed chimerism and Renal Allograft with Non-Myeloablative Conditioning in Patients with ESRD due to Multiple Myeloma
Principal Investigator:
Megan Sykes, Mass. General Hospital, Boston, MA
[
Details
] [
Clinicaltrials.gov
]
Multicenter trial of islet transplantation in type 1 diabetic patients using the Edmonton protocol
Principal Investigator:
James Shapiro, University of Alberta, Edmonton, Canada
[
Details
]
Phase I study of the treatment of multiple sclerosis with CTLA4Ig
Principal Investigator:
Samia Khoury, Brigham & Women's Hospital, Boston, MA
[
Details
] [
Clinicaltrials.gov
]
Pilot Study Using Donor Stem Cells and Campath-1H to Induce Renal Transplant Tolerance
Principal Investigator:
George W. Burke, University of Miami, FL
[
Details
] [
Clinicaltrials.gov
]
Renal allograft tolerance through mixed chimerism
Principal Investigator:
David H. Sachs, Mass. General Hospital, Boston, MA A. Benedict Cosimi, Mass. General Hospital, Boston, MA
[
Details
] [
Clinicaltrials.gov
]
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis (RAVE)
Principal Investigator:
John H. Stone, Johns Hopkins University Ulrich Specks, Mayo Clinic
[
Details
] [
Clinicaltrials.gov
]
Treatment of psoriatic arthritis with hOKT3γ(Ala-Ala): Psoriatic Arthritis Research Trial (PART)
Principal Investigator:
Marcus Clark, University of Chicago
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
